Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06517264Enrolling by invitation
Randomised, open-label trial in diverticulitis (2 arms). Primary endpoints: Therapeutic Failure (Clinical Worsening and Readmission) at 1 month and Rate of Complications at 1 month. Started Nov 2024; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06517264.